Logo del repository
  1. Home
 
Opzioni

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

Mian, Michael
•
Pescosta, Norbert
•
Badiali, Stefania
altro
Cortelazzo, Sergio
2018
  • journal article

Periodico
BRITISH JOURNAL OF HAEMATOLOGY
DOI
10.1111/bjh.15645
WOS
WOS:000472233600016
Archivio
http://hdl.handle.net/11390/1149222
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85057474613
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141
Diritti
metadata only access
Soggetti
  • bendamustine

  • dexametasone

  • myeloma

  • refractory

  • thalidomide

  • Hematology

Scopus© citazioni
4
Data di acquisizione
Jun 14, 2022
Vedi dettagli
Web of Science© citazioni
5
Data di acquisizione
Mar 26, 2024
Visualizzazioni
5
Data di acquisizione
Apr 19, 2024
Vedi dettagli
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback